|
1
|
Jenayah AA, Saoudi S, Boudaya F Bouriel I,
Sfar E and Chelli D: Ovarian vein thrombosis. Pan Afr Med J.
21(251)2015.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Plastini T, Henry D and Dunleavy K:
Ovarian vein thrombus: To treat or not to treat? Blood Advance.
1:1120–1123. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Rottenstreich A, Da'as N, Kleinstern G,
Spectre G, Amsalem H and Kalish Y: Pregnancy and non-pregnancy
related ovarian vein thrombosis: Clinical course and outcome.
Thromb Res. 146:84–88. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
See A and Chern B: Contained
intra-abdominal morcellation: Is it the way forward? Gynecol Minim
Invasive Ther. 5:99–101. 2016. View Article : Google Scholar
|
|
5
|
Bates SM, Middeldorp S, Rodger M, James AH
and Greer I: Guidance for the treatment and prevention of
obstetric-associated venous thromboembolism. J Thromb Thrombolysis.
41:92–128. 2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Assal A, Kaner JD, Danda N, Cohen HW and
Billett HH: Risk factors and prognosis of ovarian vein thrombosis.
Blood Coagul Fibrinolysis. 28:468–474. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Cassinelli G and Naggi A: Old and new
applications of non-anticoagulant heparin. Int J Cardiol. 212
(Suppl)(S14-S21)2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bos AS, Tullius T, Patel M, Leef JA,
Navuluri R, Lorenz JM and Van Ha TG: Indwelling and retrieval
complications of Denali and celect infrarenal vena cavafilters. J
Vasc Interv Radiol. 27:1021–1026. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Iliodromiti S, Mackay DF, Smith GC, Pell
JP and Nelson SM: Apgar score and the risk of cause-specific infant
mortality: A population-based cohort study. Lancet. 384:1749–1755.
2014.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Murphy EH, Johns B, Varney E and Raju S:
Endovascular management of chronic total occlusions of the inferior
vena cava and iliac veins. J Vasc Surg Venous Lymphat Disord.
5:47–59. 2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Dargaud Y, Rugeri L, Fleury C Battie C,
Gaucherand P, Huissoud C, Rudigoz RC, Desmurs-Clavel H, Ninet J and
Trzeciak MC: Personalized thromboprophylaxis using a risk score for
the management of pregnancies with high risk of thrombosis: A
prospective clinical study. J Thromb Haemost. 15:897–906.
2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Streiff MB, Agnelli G, Connors JM Crowther
M, Eichinger S, Lopes R, McBane RD, Moll S and Ansell J: Guidance
for the treatment of deep vein thrombosis and pulmonary embolism. J
Thromb Thrombolysis. 41:32–67. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Morelli VM, Lijfering WM, Bos MHA,
Rosendaal FR and Cannegieter SC: Lipid levels and risk of venous
thrombosis: Results from the MEGA-study. Eur J Epidemiol.
32:669–681. 2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Wendelboe AM and Raskob GE: Global burden
of thrombosis: Epidemiologic aspects. Circ Res. 118:1340–1347.
2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kearon C, Akl EA, Ornelas J, Blaivas A,
Jimenez D, Bounameaux H, Huisman M, King CS, Morris TA, Sood N, et
al: Antithrombotic therapy for VTE disease: CHEST guideline and
expert panel report. Chest. 149:315–352. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Farge D and Frere C: Clinical practice
guidelines for prophylaxis of venous thromboembolism in cancer
patients. Thromb Haemost. 116:618–625. 2016.
|
|
17
|
Djakovic I, Mustapic M, Marleku F, Grgic
O, Djakovic Z and Kosec V: Ovarian vein thrombosis-a case report.
Acta Clinica Belg. 70:445–446. 2015. View Article : Google Scholar
|
|
18
|
Hong-Kee N, Mei-Fong C, Azhany Y and
Zunaina E: Antiphospholipid syndrome in lupus retinopathy. Clin
Ophthalmo. 8:2359–2363. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Girolami A, Treleani M, Bonamigo E,
Tasinato V and Girolami B: Venous thrombosis in rare or unusual
sites: A diagnostic challenge. Semin Thromb Haemost. 40:81–87.
2014.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Liu M and Zhang F: Administration routes
affect thrombolytic effect of catheter-directed thrombolysis with
pro-urokinase in treating deep vein thrombosis. Ann Transl Med.
6(322)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Harris SA, Velineni R and Davies AH:
Inferior vena cava filters in pregnancy: A systematic review. J
Vasc Interv Radio. 27(354-360.e8)2016.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Angelini M, Barillari G, Londero AP,
Bertozzi S, Bernardi S, Petri R, Driul L and Marchesoni D:
Puerperal ovarian vein thrombosis: Two case reports. J
ThrombThrombolysis. 35:286–289. 2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wan Z, Xiang R, Wang H, Zhong Q and Tu B:
Comparative efficacy and safety of local and peripheral venous
thrombolytic therapy with urokinase for thrombosed hemodialysis
arteriovenous fistulas. Exp Ther Med. 17:4279–4284. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Bikdeli B, Chatterjee S, Desai NR, Kirtane
AJ, Desai MM, Bracken MB, Spencer FA, Monreal M, Goldhaber SZ and
Krumholz HM: Inferior vena cava filters to prevent pulmonary
embolism: Systematic review and meta-analysis. J Am Coll Cardiol.
70:1587–1597. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Watson L, Broderick C and Armon MP:
Thrombolysis for acute deep vein thrombosis. Cochrane Database Syst
Rev. 11(CD002783)2016.PubMed/NCBI View Article : Google Scholar
|
